
Women who received the mRNA COVID-19 vaccine in their first trimester did not have an increased risk of their child having a major congenital malformation.
Women who received the mRNA COVID-19 vaccine in their first trimester did not have an increased risk of their child having a major congenital malformation.
A new report shows Vermont, Utah, and Minnesota lead, while Louisiana, Mississippi, and Kentucky lag in Medicare performance.
Digital tools help prevent burnout, anxiety, and exhaustion among health care workers.
The government should focus on keeping up the funding for HIV to continue to innovate in this space, potentially eliminating the virus altogether.
Persistent racial, ethnic, and socioeconomic disparities affect the incidence and mortality of major female-specific cancers in the US.
Patients beginning their cancer journeys should advocate for themselves and use support groups to help navigate survivorship challenges.
Measures need to be taken to elevate engagement both from employees and the general public as public confidence in the US health care system declines.
Aspects of the average Halloween costume could pose risks to the corneal health of the eye if not applied correctly.
Nirsevimab significantly reduced RSV hospitalizations in infants, reinforcing public health recommendations for its use during the RSV season.
Long COVID is most common among adults with chronic conditions, lower physical activity, and incomplete vaccination, and who live in certain US regions.
Adults with diabetes were 24% less likely to visit an emergency department in 2021 than in 2019.
A machine learning–driven web tool based on 13 standard patient metrics demonstrates strong predictive performance for MASLD, supporting early clinical intervention.
Patients with NOTCH1 mutations derive greater benefit from BTK inhibitor treatment than from immunochemotherapy for chronic lymphocytic leukemia (CLL).
Individuals who had preoperative percutaneous transthoracic needle biopsy (PTNB) had an increased risk of local-regional recurrence in non–small cell lung cancer (NSCLC).
ACOs serving patients with complex needs are on the rise, but policy changes are needed to support providers treating special populations.
Payer contracts should incentivize the delivery of comprehensive, total-person cancer care, says Brian Mulherin, MD.
CVS Pharmacy acquires stores and prescription files from over 600 Rite Aid and Bartell Drugs pharmacies.
Vivek Subbiah, MD, highlights key topics at the 50th European Society for Medical Oncology (ESMO) Congress, including the rise of tumor-agnostic therapies and the use of artificial intelligence (AI) in cancer care.
Arthritis care remains fragmented and costly, with access disparities prompting calls for preventive strategies, community resources, and systemic improvements.
The number of Black, Hispanic, and Latino students admitted into medical schools fell as rates increased for White and Asian students.
Research highlights the need for diverse data on drug efficacy in atopic dermatitis to address barriers to treatment for patients with skin of color, notes Elain Siegfried, MD.
Eliot F. Battle, MD, discusses how to effectively and successfully treat skin of color.
Many cancer survivors face ongoing physical and mental health challenges, which peer support and online resources can help address, says Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd.
Approaching homelessness through prevention and local government policies is the next step in addressing increased incidence of homelessness, said Katherine Koh, MD, MSc.
The new indication allows doctors to use upadacitinib before tumor necrosis factor–blocking agents when those treatments are clinically inadvisable.
Opioids were more likely to be prescribed to Medicare beneficiaries living with HIV, which led to opioid use disorder (OUD).
A recent study reveals significant barriers to GLP-1 RA access for diabetes and obesity patients, highlighting racial disparities and high costs.
Despite systemic challenges, oncology practices use value-based care, community partnerships, and clinical trials to improve patient access and outcomes, says Brian Mulherin, MD.
WHO's latest report shows alarming trends in antimicrobial resistance, highlighting urgent global challenges and the need to improve surveillance and treatment.
Eliot F. Battle, MD, discusses the art of using lasers and energy-based technology to treat patients with skin of color.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.